Australia's largest stock trading and investment forum Australia's #1 stock forum

AVH

4.97%

$3.06 avita medical inc.

AVH Chart, page-411

First 411 Last

Share
Profile

Follow
hamilton66

2,311 Posts.

1549

11/04/23

16:15

Post #: 67220102
Share

Originally posted by ThaLuvDocta: ↑

57 days remain until soft tissue approval and webcast. 65 days until vitiligo approval. 82 days until sales begin for soft tissue reconstruction. 9 months until Fully Automated device approval, which will accelerate sales for all indications. 21 months until Vitiligo sales begin once reimbursement is established. Soft tissue reconstruction’s target market is 5X the current FDA-approved-and-standard-of-care’s burns target market. Vitiligo repigmentation’s target market is 5x the soft tissue reconstruction target market. International sales strategy to be announced on the Q3 Earnings Call. Positive data for soft tissue and vitiligo with no negative feedback from the FDA despite being past day 100 for both indications (google FDA 100 day meeting). Both indications are in FDA breakthrough status due to medical necessity. Gold mine stock. Highly necessary product that will still be purchased during recessions or down markets. Commercial sales grew continuously throughout Covid despite essential staff only in hospitals. Covid restrictions end in 31 days. Sales + Marketing CEO with 20 years of Baxter experience and 40 years of sales experience since September. Stars are aligning. FOMO growing.

Expand

TLD, great post mate. AVH is flying under the radar of most. Not for long. GLTA

AVH Price at posting: $4.50 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t